Effect of dry needling on dorsal myofascial pain syndrome
The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsalgia Accompanied by Myofascial Pain Syndrome.
This study is testing whether dry needling can help relieve pain and sensitivity in people with Dorsal Myofascial Pain Syndrome.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Kutahya Health Sciences University Academic / other |
| Locations | 1 site (Kütahya) |
| Trial ID | NCT06338514 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of dry needling treatment in patients diagnosed with Dorsal Myofascial Pain Syndrome. It involves a double-blind, sham-controlled, randomized trial with 60 participants aged 18 to 80 years who will receive either real or sham dry needling under ultrasound guidance. Both groups will be instructed on specific exercises to perform during the study period. The aim is to assess the impact of dry needling on pain relief and muscle sensitivity in the affected areas.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 80 with clinically diagnosed Dorsal Myofascial Pain Syndrome and a pain score of 6 or higher on the Visual Analog Scale.
Not a fit: Patients with a history of spinal surgery, skin lesions around the back, or those currently undergoing other treatments for back pain may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief and improved quality of life for patients suffering from myofascial pain.
How similar studies have performed: Previous studies have shown promising results with dry needling for myofascial pain, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinically diagnosed with Dorsal Myofascial Pain Syndrome associated with rhomboid and trapezius trigger point. * Having a shoulder pain Visual Analog Scale (VAS) score of 6 or higher. * Ability to read and write Exclusion Criteria: * History of spinal surgery. * Lesions, atrophy, or scars in the skin around the back. * Undergoing physiotherapy targeting the back and lumbar region in the last 6 months. * Undergoing an interventional procedure for back or lumbar pain in the last 3 months. * Use of steroids in the last 1 month. * Special conditions such as epilepsy, pregnancy, injection phobia, etc. * Inability to comply with the restriction on the use of steroid and non-steroidal anti-inflammatory drugs during the treatment period.
Where this trial is running
Kütahya
- Kütahya Health Sciences University — Kütahya, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Hasan H Gökpınar, Ass. Prof. — Kutahya Health Sciences University
- Study coordinator: Hasan H Gökpınar, Ass. Prof.
- Email: hasanhuseyin.gokpinar@ksbu.edu.tr
- Phone: 05052842222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.